2023 Annual Meeting | C105 - Mild Cognitive Impairment/Subjective Cognitive Impairment

Date Monday 04/24/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ronald C. Petersen, MD, PhD, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants will understand the construct of mild cognitive impairment, identify criteria for the diagnosis of MCI, use MCI as a clinical syndrome, differentiate underlying causes of MCI for treatment, develop a program for evaluating patients for pharmacotherapy, and evaluate the longitudinal outcome of patients with MCI.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student, Business Administrator

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 04:00 PM EST	Introduction	Overview of MCI Ronald C. Petersen, MD, PhD, FAAN
04:00 PM - 04:30 PM EST	Speaker	Atypical Presentations of MCI Oscar L. Lopez, MD, FAAN
04:30 PM - 05:00 PM EST	Speaker	Treatment of MCI David J. Gill, MD, FAAN
05:00 PM - 05:30 PM EST	Speaker	Case Studies Ronald C. Petersen, MD, PhD, FAAN, David J. Gill, MD, FAAN, Oscar L. Lopez, MD, FAAN

Faculty Disclosures
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
David J. Gill, MD, FAAN	Dr. Gill has nothing to disclose.
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.

��ɫ��

��ɫ��